{{Rsnum
|rsid=10495712
|Chromosome=2
|position=20973240
|Orientation=plus
|GMAF=0.1648
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 9.8 | 30.4 | 59.8
| HCB | 0.0 | 7.4 | 92.6
| JPT | 0.9 | 13.3 | 85.8
| YRI | 2.0 | 16.3 | 81.6
| ASW | 0.0 | 15.8 | 84.2
| CHB | 0.0 | 7.4 | 92.6
| CHD | 2.8 | 10.1 | 87.2
| GIH | 1.0 | 23.8 | 75.2
| LWK | 0.9 | 28.2 | 70.9
| MEX | 3.4 | 41.4 | 55.2
| MKK | 0.6 | 21.8 | 77.6
| TSI | 4.9 | 31.4 | 63.7
| HapMapRevision=28
}}{{PMID Auto
|PMID=23262498
|Title=Impact of geneticfactorsondyslipidemia in HIV-infected patients starting antiretroviral therapy
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}